Artesunate sensitizes ovarian cancer cells to cisplatin by downregulating RAD51.
Wang B, Hou D, Liu Q, Wu T, Guo H, Zhang X, Zou Y, Liu Z, Liu J, Wei J, Gong Y, Shao C.
Wang B, et al. Among authors: guo h.
Cancer Biol Ther. 2015;16(10):1548-56. doi: 10.1080/15384047.2015.1071738. Epub 2015 Jul 15.
Cancer Biol Ther. 2015.
PMID: 26176175
Free PMC article.